Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-03-04
1990-02-13
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548429, A61K 3140, C07D48700
Patent
active
049007483
ABSTRACT:
Highly potent analogs of (-)-physostigmine are provided which are potent inhibitors of acetylcholinesterase and butyrylcholinesterase. These compounds are useful in treatment of glaucoma, Alzheimer's disease, myasthenia gravis, and organophosphate poisoning.
REFERENCES:
patent: 2909530 (1959-10-01), Rudner
patent: 4278667 (1981-07-01), Madison et al.
patent: 4278679 (1981-07-01), Madison et al.
patent: 4647580 (1987-03-01), Roszkowski
patent: 4661509 (1987-04-01), Gordon et al.
Kawabuchi, et al., Synapse, vol. 2, pp. 139-147 (1988).
Yu, et al., Heterocycles, vol. 27, No. 3, (1988) pp. 745-750.
Yu, et al., FEBS Letters, vol. 234, No. 1, pp. 127-130, (1988).
Chemical Abstracts 102:214989c (1985).
Chemical Abstracts 105:72467s (1986).
Atack John R.
Brossi Arnold
Rapoport Stanley I.
Yu Qian-Sheng
Ford John M.
The United States of America as represented by the Department of
Whittenbaugh Robert C.
LandOfFree
Carbamates related to (-)-physostigmine as cholinergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamates related to (-)-physostigmine as cholinergic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamates related to (-)-physostigmine as cholinergic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168407